These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 21494798)

  • 1. Visfatin levels in Behcet's disease.
    Sezen H; Okumus S; Pehlivan Y; Dilli I; Tarakcioğlu M; Onat AM
    Inflammation; 2012 Apr; 35(2):405-8. PubMed ID: 21494798
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Visfatin levels and intima-media thicknesses in rheumatic diseases.
    Ozgen M; Koca SS; Aksoy K; Dagli N; Ustundag B; Isik A
    Clin Rheumatol; 2011 Jun; 30(6):757-63. PubMed ID: 21165753
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vascular endothelial growth factor levels are increased and associated with disease activity in patients with Behçet's syndrome.
    Cekmen M; Evereklioglu C; Er H; Inalöz HS; Doganay S; Türköz Y; Ozerol IH
    Int J Dermatol; 2003 Nov; 42(11):870-5. PubMed ID: 14636202
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum interleukin 18 and tumour necrosis factor-alpha levels are increased in Behcet's disease.
    Oztas MO; Onder M; Gurer MA; Bukan N; Sancak B
    Clin Exp Dermatol; 2005 Jan; 30(1):61-3. PubMed ID: 15663506
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum interleukin-2, interleukin-6, tumour necrosis factor-alpha and nitric oxide levels in patients with Behcet's disease.
    Akdeniz N; Esrefoglu M; Keleş MS; Karakuzu A; Atasoy M
    Ann Acad Med Singap; 2004 Sep; 33(5):596-9. PubMed ID: 15531955
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytokine inhibitors: soluble tumor necrosis factor receptor 1 and interleukin-1 receptor antagonist in Behçet's disease.
    Düzgün N; Ayaşlioğlu E; Tutkak H; Aydintuğ OT
    Rheumatol Int; 2005 Jan; 25(1):1-5. PubMed ID: 14600787
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elevated serum interleukin 1 receptors and interleukin 1B in patients with Behçet's disease: correlations with disease activity and severity.
    Yosipovitch G; Shohat B; Bshara J; Wysenbeek A; Weinberger A
    Isr J Med Sci; 1995 Jun; 31(6):345-8. PubMed ID: 7607852
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Levels of circulating intercellular adhesion molecule-1 in patients with Behçet's disease.
    Saglam K; Yilmaz MI; Saglam A; Ulgey M; Bulucu F; Baykal Y
    Rheumatol Int; 2002 Jan; 21(4):146-8. PubMed ID: 11843169
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum Cytokine Levels in Behçet's Disease.
    Akkurt ZM; Bozkurt M; Uçmak D; Yüksel H; Uçak H; Sula B; Gürsel Özkurt Z; Yildiz M; Akdeniz D; Arica M
    J Clin Lab Anal; 2015 Jul; 29(4):317-20. PubMed ID: 25130392
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum MMP-2 and MMP-9 in patients with Behçet's disease: do their higher levels correlate to vasculo-Behçet's disease associated with aneurysm formation?
    Pay S; Abbasov T; Erdem H; Musabak U; Simsek I; Pekel A; Akdogan A; Sengul A; Dinc A
    Clin Exp Rheumatol; 2007; 25(4 Suppl 45):S70-5. PubMed ID: 17949555
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The relationship between serum prolactin levels and disease activity in patients with Behcet's disease.
    Atasoy M; Karatay S; Yildirim K; Kadi M; Erdem T; Senel K
    Cell Biochem Funct; 2006; 24(4):353-6. PubMed ID: 15898123
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of plasma visfatin with hepatic and systemic inflammation in nonalcoholic fatty liver disease.
    Genc H; Dogru T; Kara M; Tapan S; Ercin CN; Acikel C; Karslioglu Y; Bagci S
    Ann Hepatol; 2013; 12(4):548-55. PubMed ID: 23813132
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased serum interleukin-32 levels in patients with Behçet's disease.
    Ha YJ; Park JS; Kang MI; Lee SK; Park YB; Lee SW
    Int J Rheum Dis; 2018 Dec; 21(12):2167-2174. PubMed ID: 28378461
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum leptin concentration is increased in patients with Behçet's syndrome and is correlated with disease activity.
    Evereklioglu C; Inalöz HS; Kirtak N; Doganay S; Bülbül M; Ozerol E; Er H; Ozbek E
    Br J Dermatol; 2002 Aug; 147(2):331-6. PubMed ID: 12174107
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation between IL-17A/F, IL-23, IL-35 and IL-12/-23 (p40) levels in peripheral blood lymphocyte cultures and disease activity in Behcet's patients.
    Sonmez C; Yucel AA; Yesil TH; Kucuk H; Sezgin B; Mercan R; Yucel AE; Demirel GY
    Clin Rheumatol; 2018 Oct; 37(10):2797-2804. PubMed ID: 29557072
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synovial proinflammatory cytokines and their correlation with matrix metalloproteinase-3 expression in Behçet's disease. Does interleukin-1beta play a major role in Behçet's synovitis?
    Pay S; Erdem H; Pekel A; Simsek I; Musabak U; Sengul A; Dinc A
    Rheumatol Int; 2006 May; 26(7):608-13. PubMed ID: 16205926
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The relationship of visfatin levels to inflammatory cytokines and left ventricular hypertrophy in hemodialysis and continuous ambulatory peritoneal dialysis patients.
    Erten Y; Ebinç FA; Ebinç H; Paşaoğlu H; Demirtaş C; Taçoy G; Koç E; Derici U; Reis KA; Bali M; Arinsoy T; Sindel S
    Ren Fail; 2008; 30(6):617-23. PubMed ID: 18661412
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of resistin in Behçet's disease: a Turkish experiment.
    Pehlivan Y; Onat AM; Okumuş S; Kisacik B; Comez G; Comez A; Goktepe F; Ceylan NO
    Mod Rheumatol; 2012 Aug; 22(4):571-5. PubMed ID: 22038316
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fractalkine (CX3CL1) levels in patients with Behçet's disease and neuro-Behçet's disease.
    Ceyla I; Tuba TK; Adisen E; Banu O; Isil F; Ali GM; Turgut I; Banu B
    J Neurol Sci; 2012 Apr; 315(1-2):120-2. PubMed ID: 22177089
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum leptin levels in patients with ocular and nonocular Behçet's disease.
    Yalçindağ FN; Kisa U; Batioğlu F; Yalçindağ A; Ozdemir O; Cağlayan O
    Mediators Inflamm; 2007; 2007():31986. PubMed ID: 17641728
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.